Back
uniQure NV 10K Form
Sell
36
QURE
uniQure NV
Last Price:
$27.51
Seasonality Move:
25.75%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive QURE News And Ratings
See the #1 stock for the next 7 days that we like better than QURE
QURE Financial Statistics
Sales & Book Value
| Annual Sales: | $27.1M |
|---|---|
| Cash Flow: | $-43.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.07 |
| Price / Book: | 22.23 |
Profitability
| EPS (TTM): | -3.92000 |
|---|---|
| Net Income (TTM): | $-199M |
| Gross Margin: | $-3.8M |
| Return on Equity: | -565.78% |
| Return on Assets: | -31.86% |
uniQure NV Earnings Forecast
Key uniQure NV Financial Ratios
-
The Gross Profit Margin over the past 15 years for QURE is -14.19%.
-
The Selling, General & Administrative Expenses for QURE have been equal to 194.17% of Gross Profit Margin.
-
The Research & Development expenses have been 522.26% of Revenue.
-
The Net Earning history of QURE is -883.35% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 6 years.
uniQure NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | QURE |
| CUSIP: | N90064 |
| Website: | uniqure.com |
Debt
| Debt-to-Equity Ratio: | -130.39 |
|---|---|
| Current Ratio: | 9.98 |
| Quick Ratio: | 9.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
QURE Technical Analysis vs Fundamental Analysis
Sell
36
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy or a Sell?
-
uniQure NV stock is rated a SellThe current uniQure NV [QURE] share price is $26.06. The Score for QURE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.